Bausch Health is a global specialty pharmaceutical and medical device company with five core operating segments: Salix (gastrointestinal products including the leading branded drug Xifaxan), International (branded and generic pharmaceuticals and OTC products across markets outside North America), Solta Medical (aesthetic medical devices), Diversified (neurology, dermatology, generics, and dentistry products for the U.S. market), and Bausch + Lomb (a fully integrated eye health business offering vision care products, surgical systems, and pharmaceuticals for dry eye and other conditions). The company markets its products across approximately ninety countries, with the United States accounting for roughly sixty percent of revenue, and generates revenue through sales of branded pharmaceuticals, generic drugs, over-the-counter products, and medical devices distributed through wholesalers, pharmacies, hospitals, and physicians via direct sales, consumer advertising, and distribution networks.